SironRX Therapeutics Secures $3,400,000 Series A Funding

  • Feed Type
  • Date
    8/17/2011
  • Company Name
    SironRX Therapeutics
  • Mailing Address
    10000 Cedar Avenue Cleveland, OH 44106
  • Company Description
    SironRX is developing novel therapies exclusively licensed from Juventas Therapeutics and Cleveland Clinic that promote wound repair and prevent scarring of dermal wounds.
  • Website
    http://www.sironrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,400,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We will use the funds to build the SironRX team and execute on key clinical-stage milestones.
  • M&A Terms
  • Venture Investor
    North Coast Angel Fund
  • Venture Investor
    Jumpstart
  • Venture Investor
    Fletcher Spaght Ventures
  • Venture Investor
    Glengary
  • Venture Investor
    Ohio TechAngels Fund
  • Venture Investor
    Early Stage Partners

Trending on Xconomy